Analytical Tools to Accelerate Deformulation of OINDPs
For complex generic pharmaceutical products such as locally-acting nasal sprays, the US Food and Drug Administration's (FDA) guidance outlines methods for determining the equivalence of physicochemical properties between the reference listed drug product (RLD) and the test product as a key step on the route to determining bioequivalence in-vitro.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.